Literature DB >> 26228782

ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part I - Assessment and Management of Various Cardiovascular Risk Factors.

Angela Yee Moon Wang1, K Scott Brimble2, Gillian Brunier3, Stephen G Holt4, Vivekanand Jha5, David W Johnson6, Shin-Wook Kang7, Jeroen P Kooman8, Mark Lambie9, Chris McIntyre10, Rajnish Mehrotra11, Roberto Pecoits-Filho12.   

Abstract

Cardiovascular disease contributes significantly to the adverse clinical outcomes of peritoneal dialysis (PD) patients. Numerous cardiovascular risk factors play important roles in the development of various cardiovascular complications. Of these, loss of residual renal function is regarded as one of the key cardiovascular risk factors and is associated with an increased mortality and cardiovascular death. It is also recognized that PD solutions may incur significant adverse metabolic effects in PD patients. The International Society for Peritoneal Dialysis (ISPD) commissioned a global workgroup in 2012 to formulate a series of recommendations regarding lifestyle modification, assessment and management of various cardiovascular risk factors, as well as management of the various cardiovascular complications including coronary artery disease, heart failure, arrhythmia (specifically atrial fibrillation), cerebrovascular disease, peripheral arterial disease and sudden cardiac death, to be published in 2 guideline documents. This publication forms the first part of the guideline documents and includes recommendations on assessment and management of various cardiovascular risk factors. The documents are intended to serve as a global clinical practice guideline for clinicians who look after PD patients. The ISPD workgroup also identifies areas where evidence is lacking and further research is needed.
Copyright © 2015 International Society for Peritoneal Dialysis.

Entities:  

Keywords:  Cardiovascular risk; anemia; dialysate calcium; dyslipidemia; glycosylated hemoglobin; hypertension; hypokalemia; inflammation; obesity; peritoneal dialysis; residual renal function; salt; volume

Mesh:

Year:  2015        PMID: 26228782      PMCID: PMC4520720          DOI: 10.3747/pdi.2014.00279

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  49 in total

1.  Effect of fluid and sodium removal on mortality in peritoneal dialysis patients.

Authors:  K Ateş; G Nergizoğlu; K Keven; A Sen; S Kutlay; S Ertürk; N Duman; O Karatan; A E Ertuğ
Journal:  Kidney Int       Date:  2001-08       Impact factor: 10.612

2.  Standards of medical care in diabetes--2014.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

3.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

Review 4.  Mechanisms of hypokalemia-induced ventricular arrhythmogenicity.

Authors:  Oleg E Osadchii
Journal:  Fundam Clin Pharmacol       Date:  2010-10       Impact factor: 2.748

Review 5.  Exercise training for adults with chronic kidney disease.

Authors:  Susanne Heiwe; Stefan H Jacobson
Journal:  Cochrane Database Syst Rev       Date:  2011-10-05

6.  Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study.

Authors:  Edwina A Brown; Simon J Davies; Peter Rutherford; Frederique Meeus; Mercedes Borras; Werner Riegel; Jose C Divino Filho; Edward Vonesh; Monique van Bree
Journal:  J Am Soc Nephrol       Date:  2003-11       Impact factor: 10.121

7.  Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function.

Authors:  S L S Fan; T Pile; S Punzalan; M J Raftery; M M Yaqoob
Journal:  Kidney Int       Date:  2007-10-03       Impact factor: 10.612

8.  Blood pressure and mortality risk on peritoneal dialysis.

Authors:  Udaya P Udayaraj; Retha Steenkamp; Fergus J Caskey; Chris Rogers; Dorothea Nitsch; David Ansell; Charles R V Tomson
Journal:  Am J Kidney Dis       Date:  2008-11-22       Impact factor: 8.860

9.  Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD.

Authors:  Hiromichi Suzuki; Yoshihiko Kanno; Soichi Sugahara; Hirokazu Okada; Hidetomo Nakamoto
Journal:  Am J Kidney Dis       Date:  2004-06       Impact factor: 8.860

Review 10.  Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.

Authors:  Juan P Casas; Weiliang Chua; Stavros Loukogeorgakis; Patrick Vallance; Liam Smeeth; Aroon D Hingorani; Raymond J MacAllister
Journal:  Lancet       Date:  2005-12-10       Impact factor: 79.321

View more
  28 in total

1.  Nonparallel Progression of Left Ventricular Structure and Function in Long-Term Peritoneal Dialysis Patients.

Authors:  Qiuhong Shi; Jing Zhu; Sheng Feng; Huaying Shen; Jianchang Chen; Kai Song
Journal:  Cardiorenal Med       Date:  2017-04-22       Impact factor: 2.041

2.  Association of body mass index and uncontrolled blood pressure with cardiovascular mortality in peritoneal dialysis patients.

Authors:  Wei Li; Ricong Xu; Yating Wang; Jiani Shen; Zhijian Li; Xueqing Yu; Haiping Mao
Journal:  J Hum Hypertens       Date:  2018-09-12       Impact factor: 3.012

3.  Low prognostic nutritional index associated with cardiovascular disease mortality in incident peritoneal dialysis patients.

Authors:  Fenfen Peng; Wenjing Chen; Weidong Zhou; Peilin Li; Hongxin Niu; Yihua Chen; Yan Zhu; Haibo Long
Journal:  Int Urol Nephrol       Date:  2017-02-10       Impact factor: 2.370

Review 4.  The Current State of Peritoneal Dialysis.

Authors:  Rajnish Mehrotra; Olivier Devuyst; Simon J Davies; David W Johnson
Journal:  J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 10.121

Review 5.  Development of a framework for minimum and optimal safety and quality standards for hemodialysis and peritoneal dialysis.

Authors:  Laura Sola; Nathan W Levin; David W Johnson; Roberto Pecoits-Filho; Harith M Aljubori; Yuqing Chen; Stefaan Claus; Allan Collins; Brett Cullis; John Feehally; Paul N Harden; Mohamed H Hassan; Fuad Ibhais; Kamyar Kalantar-Zadeh; Adeera Levin; Abdulkarim Saleh; Daneil Schneditz; Irma Tchokhonelidze; Rumeyza Turan Kazancioglu; Ahmed Twahir; Robert Walker; Anthony J O Were; Xueqing Yu; Fredric O Finkelstein
Journal:  Kidney Int Suppl (2011)       Date:  2020-02-19

6.  Biocompatibility of a new PD solution for Japan, Reguneal™, measured as in vitro proliferation of fibroblasts.

Authors:  Bart Dioos; Goedele Paternot; Rose-Marie Jenvert; Annick Duponchelle; Mark R Marshall; Migaku Nakajima; Edward Ramirez Ganoza; James A Sloand; Anders P Wieslander
Journal:  Clin Exp Nephrol       Date:  2018-06-20       Impact factor: 2.801

7.  Study on the Prevalence of Vascular Calcification in Different Types of Arteries and Influencing Factors in Maintenance Peritoneal Dialysis Patients.

Authors:  Qingyu Niu; Huiping Zhao; Bei Wu; Shihming Tsai; Jian Wu; Meng Zhang; Lixia Lu; Jie Qiao; Chuncui Men; Li Zuo; Mei Wang
Journal:  Blood Purif       Date:  2019-01-30       Impact factor: 2.614

8.  [Effect of dietary sodium intake on residual renal function in patients undergoing peritoneal dialysis: a prospective study of 33 cases].

Authors:  Jianxia Hu; Liping Hu; Nirong Gong; Lei Zhang; Jianwei Tian; Jianping Jiang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-06-30

9.  Serum Magnesium Levels and Hospitalization and Mortality in Incident Peritoneal Dialysis Patients: A Cohort Study.

Authors:  Xiao Yang; Melissa Soohoo; Elani Streja; Matthew B Rivara; Yoshitsugu Obi; Scott V Adams; Kamyar Kalantar-Zadeh; Rajnish Mehrotra
Journal:  Am J Kidney Dis       Date:  2016-06-01       Impact factor: 8.860

10.  Biocompatible dialysis fluids for peritoneal dialysis.

Authors:  Htay Htay; David W Johnson; Kathryn J Wiggins; Sunil V Badve; Jonathan C Craig; Giovanni Fm Strippoli; Yeoungjee Cho
Journal:  Cochrane Database Syst Rev       Date:  2018-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.